The influence of MT-2 tropism on the prognostic implications of the Δ32 deletion in the CCR-5 gene

AIDS

Volumn 11, Issue 12, 1997, Pages 1415-1419

  Bratt, Göran ^a   Sandström, Eric ^a   Albert, Jan ^b   Samson, Michel ^c   Wahren, Britta ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

CCR 5; Heterozygote; HIV 1 coreceptor; Long term non progression; MT 2 tropism; 32 deletion

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR;

ADULT; ARTICLE; BRONCHITIS; CLINICAL ARTICLE; COLITIS; CYTOMEGALOVIRUS INFECTION; GENE DELETION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL;

EID: 0030814510     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199712000-00005     Document Type: Article

References (25)

1. Garred P, Madsen HO, Balslev U, et al.: Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 1997, 349:236-240.
2. McNeil AJ, Yap PL, Corp SM, et al.: Association of HLA types A1-B8-DR3 and 827 with rapid and slow progression of HIV disease. QJM 1996, 89:177-185.
3. Koot M, Vos AHV, Keet RPM, et al.: HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992, 6:49-54.
4. Schellekens P, Koot M, Roos M, Tersmette M, Miedema F: Immunologic and virologic markers determining progression to AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10 (suppl 2):S62-S65.
5. Choe H, Farzan M, Sun Y, et al.: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148.
6. Dragic T, Litwin V, Allaway C, et al.: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
7. Deng H, Liu R, Ellmeier W, et al.: Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
8. Alkhatib G, Combafiere C, Broder C, et al.: CC CKR5: A RANTES, MIP-lα, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Seience 1996, 272:1955-1958.
9. Feng Y, Broder C, Kennedy P, Berger E: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, C protein-coupled receptor. Science 1996, 272:872-877.
10. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P: Identification of RANTES, MIP-lα and MIP-1β as the major HIV-suppressive factors produced by CD8+ T-cells. Science 1995, 270:1811-1815.
11. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M: Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996, 35:3362-3367.
12. Jansson M, Popovic M, Karlsson A, et al.: Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci USA 1996, 93:15382-15387.
13. Samson M, Libert F, Doranz B, et al.: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
14. Dean M, Carrington M, Winkler C, et al.: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996, 273:1856-1862.
15. Eugen-Olsen I, Iversen AKN, Garred P, et al.: Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HlV-seropositive individuals. AIDS 1997, 11:305-310.
16. Michael NL, Chang C, Louie LG, et al.: The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997, 3:318-340.
17. Ho D: Viral count in HIV infection. Science 1996, 272:1124-1125.
18. Karlsson A, Parsmyr K, Sandström E, Fenyö EM, Albert J: MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type I infection. J Clin Microbiol 1994, 32:364-370.
19. Connor RI, Mohri H, Cao Y, Ho DD: Increased viral burden and cytopathicity correlate temporarily with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type I-infected individuals, Virol 1993, 67:1772-1777
20. Fouchier R, Groenink M, Kootstra NA, et al.: Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp 120 molecule. J Virol 1992, 66:3138-3187.
21. Bratt GA, Leandersson L, Eriksson L, et al.: Four years experiences of VaxSyn HIV-1 in asymptomatic HIV-positive individuals. XI International Conference on AIDS. Vancouver, Inly 1996 [abstract WeB 3374].
22. Scarlatti G, Lombardi V, Plebani A, et al.: Polymerase chain reaction, virus isolation and antigen assay in HIV-1 antibody positive mothers and their children. J Acquir Immune Defic Syndr 1991, 5:1173-1178.
23. Rutherford GW, Lifson SR, Hessol NA, Darrow WW, O'Malley PM, Buchbinder SP: Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. DMJ 1990, 301:1183-1188.
24. Philips AN, Lee CA, Elford I, et al.: Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991, 337:389-392.
25. Munoz A, Carey V, Saah AJ, et al.: Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1988, 4:396-404.